Sangamo Biosciences (SGMO) R&D EVP Resigns

October 19, 2016 7:47 AM EDT

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Sangamo Biosciences (Nasdaq: SGMO) disclosed the following in a U.S. SEC filing on Tuesday:

Item 5.02. - Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers; Compensatory Arrangements of Certain Officers.

On October 12, 2016, Geoffrey Nichol, M.B., Ch.B., notified Sangamo BioSciences, Inc. of his resignation as Executive Vice President, Research and Development effective October 25, 2016.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Corporate News, Hot Corp. News, Management Changes

Add Your Comment